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ABSTRACT OF THE THESIS

Distraction of Heterotopic Bone Formed with BMP-2 in a Rat Model: The Technique

Stacie Dawn Fenderson

Master of Science, Graduate Program in Orthodontics
Loma Linda University, December, 2007
Dr. Philip Boyne, Chairperson

Multiple studies have shown that ectopic bone forms when bone morphogenic
proteins (for example BMP-2 and BMP-7)and a collagen matrix are surgically placed in
th

a rat model either orthotopically or heterotopically. Bone begins to form by the 14 day,

and is at it maximum calcified state by the 2U'day. No study to date has shown what
would result from application of force on this ectopic bone. The purpose ofthis study is
to observe and quantify the effect of distraction osteogenesis on the ectopic bone. First, a
preliminary procedure was performed by surgically placing a titanium cage into the back
of a rat just caudal to the thoracic vertebrae. The anterior comers were sutured to the
spinotrapezius muscle for stabilization. The titanium cage containing rhBMP-2 in a
collagen carrier was allowed to form bone for 21 days. It was then retrieved and
prepared with TRAP stain to observe osteoclast activity. A high osteoclast activity

would have indicated that the concentration of BMP-2 might be to high, and the same test

would be repeated with a lower concentration. According to Dr. Andresen, various
concentrations of BMP-2 had no significant effect on bone formation when used as a

bone graft. Once a dose and concentration was established for the optimal bone growth
all further studies were done at that concentration. The specimens were evaluated grossly

and histologically for comparison. The dose was given by Medtronics to be 1.4ml of

rhBMP-2 per sponge. Between one and one and a half sponges were used per rat. The
concentration that formed the most bone was 0.3mg/ml, when compared to O.lmg/ml.
The second phase ofthe experiment evaluated the effects ofexpansion by using a
distractor like those used in clinical distraction osteogenesis. Instead ofremoving the
cage at 21 days, the forming bone was cut with a 15 blade at day 14 between the two

cages attached to the distractor. It was then allowed to "heal" for 1 day, after which

expansion began. The rate of expansion was 2/3mm per day for 7 days. A7 day latency
period followed expansion before removal and examination ofthe expanded bone. The
bone continued to form beyond 21 days in both types ofcages (i.e. distraction and non-

expansion). Specimens obtained for evaluation with CT,histology, and grossly.

CHAPTER ONE

INTRODUCTION

In 1965 Marshall R. Urist characterized a protein moiety responsible for the

induction of bone growth.^^ This protein material later became known as "bone
morphogenic protein". It wasn't until Wozney et al. identified the genetic sequence of
bone morphogenic protein, that the various isoforms were developed using recombinant

gene technology.'"^ The hallmark function of bone morphogenic protein is its ability to
induce bone, cartilage, ligament, and tendon formation at both orthotopic and

heterotopic sites. Several studies'"''^''^'^^'^^have illustrated the potential of bone
morphogenic proteins to enhance spinal fusion, repair critical-size defects, accelerate

union, and heal articular cartilage. Bone morphogenic proteins have significant promise
for potential applications in medical, dental, and veterinary practice for the treatment of

cartilage and bone-related diseases.® We know that forces, whether tension or pressure,
are required to maintain bone; and although many studies have looked at the formation

of ectopic bone due to BMP-2,it has yet to be shown what would happen if forces were
placed on this ectopic bone. If ectopic bone could remodel and continue to regenerate,
then we would have a way to clinically create the size and shape of bone we needed for

subsequent transplant procedures without the need for an actual bone grafting. This
would decrease the probability of rejection if an allograft were to be used, and in most

cases eliminate the need for an autograft. The purpose of this study is to determine if
heterotopic bone will regenerate following implantation of BMP-2 and continue to
respond to the stimulation of distraction osteogenesis.

CHAPTER TWO
REVIEW OF LITERATURE

Modern technology has decreased the need for organ and tissue donors or even

autograft donor sites. A number of studies carried out over the past 20 years have helped

to elucidate the roles of BMPs. Although much progress has been made, there are many
questions left unanswered. The concept that there is a substance in bone that can induce
new bone formation was recognized by Marshall R. Urist in 1965 when he observed that
a new ossicle had formed after the implantation of demineralized bone matrix in a

muscle pouch of a rat. He termed this phenomenon the bone induction principle and
later identified a protein responsible for this effect, to which he gave the name bone

morphogenic protein.^' More than twenty years later, in 1988, Wozney et al. identified
the genetic sequence of bone morphogenic protein, which led to the identification of its

various isoforms. With this genetic information it is now possible to produce various
BMPs with the use of recombinant gene technology.'"^

Bone morphogenic proteins(BMPs)are multifactoral growth factors belonging to
the transforming growth factor-beta superfamily. Family members are expressed during
limb development, endochondral ossification, early fracture, and cartilage repair. The
activity of BMPs was first identified in the 1960s but the proteins responsible for bone
induction were unknown until the purification and cloning of human BMPs in the 1980s.
Up until 2005, about 15 BMP family members were identified and characterized (More

than 20 have been identified since). The signal triggered by BMPs is transduced through
serine/threonine kinase receptors. BMPs seem to be involved in the regulation of cell

proliferation, survival, differentiation and apoptosis, but their hallmark is their ability to
induce bone, cartilage, ligament, and tendon formation at both heterotopic and
orthotopic sites. This suggests that, in the future, they may play a role in the treatment

of bone diseases. Several studies'^'''*'^®have illustrated the potential of BMPs to enhance
spinal fusion, repair critical-size defects, accelerate union, and heal articular cartilage
lesions. Difficulties in producing and purifying BMPs from bone tissue have prompted
the laboratories to express these proteins in the recombinant form in heterologous

systems. ® In this experiment, we will be looking at rhBMP-2 almost exclusively and the
role it plays in bone regeneration.

Bone morphogenic protein 2, or BMP-2,is a protein that induces the formation of

bone and cartilage. The gene for BMP-2 is on chromosome 20 in band 20pl2.3. Three
sets of variations within the BMP-2 gene reportedly triple the risk of developing
osteoporosis. Bone morphogenic protein induces ectopic bone formation, and plays an

important role in the development of the viscera.'^
Mandibular distraction osteogenesis is a well-developed clinical modality for the
treatment of craniofacial deformities and dental arch discrepancies, in combination with
orthodontic treatment. However, other studies have shown that orthodontic tooth

movement into the distraction gap caused severe root resorption. The question of
whether or not gene expression of osteoclastogenic and osteoclast supporting molecules

released by osteoblasts and stromal cells would increase at distraction sites during the
consolidation period. The number of osteolclasts was larger in the distraction gap during
the early consolidation period than in normal controls, due to an increase of gene
expression for osteoclastogenic cytokines in osteoblasts. The conclusion was that

osteoclastogenic and osteoclast activities are stimulated at the distraction sites during the

early consolidation period.^® This research is useful to note clinically, and raises the
question whether, if BMP-2 was injected into the consolidation zone, it would
consolidate faster enabling the orthodontist to move teeth into that area sooner?

In one of the first published studies with BMPs,the researchers used an aggregate
of partially purified bovine bone morphogenic protein(bBMP)and bone matrix insoluble
non-collagenous proteins(iNCP). A total of 100 mg of lyophilized BMP/iNCP was

implanted, using ultra thin gelatin capsules, in skull trephine defects in adult sheep. In
two out of five sheep, the 20 mm skull trephine defects were repaired with bone as early

as four weeks after the operation. Eight to 12 weeks after surgery repair was complete in
the other three sheep. In the control contralateral trephines, one-third to one half of the

defect was incompletely repaired. Neither the BMP nor the BSA control implants
induced bone formation in the muscle, while the BMP/iNCP prepared from bovine bone
consistently induced regeneration in skull trephine defects; only fibrous tissue and no

extraskeletal bone was induced to form in cervical muscle pouches in sheep.'^ This
research is important because it shows that a BMP complex is effective even across
species, or as a xenograph.

Another study published that same year looked specifically at heterotopic bone
formation(HO)as an unsolved problem occurring in response to a variety of conditions
including muscle contusions, injuries, surgical procedures and burns. A sensitive
method for quantification of HO would be valuable for experimental work and research
on bone morphogenic protein (BMP). Roentgenograms, CT scans, MRIs and the like
provide a rapid and highly accurate method for determining the amount of HO in a

muscle. Using the mouse thigh pouch as an experimental system, this method
demonstrated that quantities of new bone were formed in direct proportion to the amount
of BMP/iNCP implanted. This system can be used for measuring HO on
roentgenograms or any other image, including computed tomographic(CT)scans,

magnetic resonance imaging (MRI), and autoradiograms.'^ It is important to remember
that heterotopic bone formation can result simply from a surgical procedure.

A research article published in Germany^^ compared ectopic with orthotopic bone
formed in a rat model. The method of this study was to construct a vascularized bone
graft using osteoinductive rh-BMP-2, a polylactic acid matrix (OPLA/HY), and a

vascularized periosteal flap containing osteoprogenitor cells implanted ectopically in the

groin or orthotopically in a femoral defect of a Lewis rat. The presence and density of
new bone formation in the groin and femoral defect were evaluated radiologically and
histologically at 4 and 8 weeks. Good bone formation in the groin chamber (ectopic) was
demonstrated in the periosteal flap + OPLA/HY + BMP group. However, with the
presence of a vascularized periosteal flap, more bone formation along the rim of the
defect was observed. This study demonstrates that optimal bone formation requires four

factors: BMP,a biodegradable matrix, osteoprogenitor cells, and a blood supply. In the
future, this technique could potentially be used to reconstruct a bony defect or a nonunion
by covering the involved area with a vascularized periosteal flap and a suitable matrix

combined with BMP. Alternatively, a vascularized bone graft could be prefabricated at a
distant site and then transferred via microsurgery into a defect.^

As in the previous study, Stoeger^^ used the technological advances in genetics to
test recombinant human bone morphogenic protein-2(rhBMP-2), along with a

commercial collagen type I carrier, in examining the molecular progression of ectopic
bone development in the hind quarter muscles of mice. A gene expression study was
performed using mRNA in situ hybridization to compare embryonic cartilage and bone
formation with BMP-2 induced ectopic bone formation. It was found that the mRNAs

encoding the same molecules, such as Indian hedgehog (IHH), parathyroid hormone
(PTH), PTH-related peptide receptor(PPR)and BMPs,that regulate embryonic cartilage
and bone development, are expressed during BMP-induced ectopic bone formation,

suggesting parallels in mechanisms controlling these processes. Stoeger's molecular data
support the previous studies done on rats showing that BMP-2 induced ectopic bone
formation in mice undergoes bone development involving both modes, endochondral and

intramembranous ossification, simultaneously at different sites of the implant.

A study conducted in Japan'^ analyzes the steps involved in ectopic bone
formation. The purpose of the study was to investigate the characteristics of ectopic
chondroid/bone matrix and chondrogenic/osteogenic cells induced by recombinant
human BMP-2. Five micrograms of rhBMP-2 combined with atelocollagen (used as the
collagen matrix) was implanted into the calf muscle of rats and removed on days 7, 10,
14, 21, or 28. Tissue sections were examined using; (i) hematoxylin/Alcian blue/Sirius
red stain,(ii) enzyme histochemistry for alkaline phosphatase(ALP)and tartrate-resistant

acid phosphatase activity,(iii) immunohistochemistry for types I, II, and X collagen, and
(iv) electron microscopy. On day 7, numerous fibroblast-like cells with ALP activity
were present on the pellet rim. By day 10, chondroid matrix(CM)had formed,
containing both type I collagen and proteoglycans, and often continued into the BMP

pellet. On day 14, bone-like matrix formed around hypertrophic chondrocytes as part of

the endochondral ossification process. Co-expression of types I and II collagen within
chondrocytes and osteocytes was observed throughout the course of the experiment.
These results suggest that fibroblast-like cells invading the pellet differentiate into
chondrocytes and form CM under the scaffold of the carrier component. It appears that
some chondrocytes change their phenotype to produce the bone-like matrix and remain

within the endochondral bone. This process enables rapid osteogeneis to occur.

Another study done in Japan^^ attempted to chemically engineer a substance in
order to prolong the calcification of ectopic bone. A synthetic peptide corresponding to
residues 73-92 of BMP-2 was investigated. This peptide bound to a BMP-2-specific
receptor elevated both alkaline phosphatase activity and osteocalcin mRNA in a murine

cell line. The 73-92 peptide also induced ectopic calcification when conjugated to a
covalently cross-linked alginate gel. The 73-92 peptide-conjugated alginate gel showed
prolonged ectopic calcification for up to 7 weeks in rat calf muscle. In contrast, rhBMP-

2-impregnated collagen gel showed maximum ectopic calcification at three weeks, and
the calcified products that had formed disappeared after 5 weeks. Histological
examination showed that the 73-92 peptide-conjugated alginate gel induced many
osteoblast-like cells and few osteoclasts. In contrast, rhBMP-2-impregnated collagen gel
induced many osteoclasts. These results suggest that the 73-92 peptide on alginate gel
remains active at the implant site, continuously inducing differentiation of osteoblast

precursor cells into osteoblasts, and activates osteoblasts to promote ectopic
calcification.^^

Another study used implants of collagen combined with adenoviral vector
containing the BMP-2 gene(AdBMP-2) placed subcutaneously in rats to induce bone

formation. In this same study they also evaluated whether targeting the AdBMP-2 vector
through an alternative pathway,fibroblast growth factor(FGF), would increase the
vector's potency. It was found that local delivery of AdBMP-2 in a collagen matrix
rapidly induced bone formation within 14 days, and targeting the virus through FGF

receptors significantly enhanced the osteogenic potential of AdBMP-2.^ This research
suggests that combining the effects of growth factors might induce a synergistic effect on
bone formation.

BMPs have also been used in distraction osteogenesis. One experimental study in
sheep performed alveolar ridge augmentation by distraction osteogenesis using BMP-2
to enhance bone regeneration, followed by implant placement. The average amount of

distraction was 12 mm,the distance was held for 12 weeks, then a biopsy was taken.
Then titanium cylindrical implants were placed in the newly augmented bone. The
histological study demonstrated that the association of DO and BMP-2 resulted in

increased trabecular bone size and volume. They found that alveolar distraction
augments atrophic ridge and creates new bone that permits implant placement. rhBMP-2
enhances bone quality and may shorten the consolidation period of distraction allowing

for earlier implant placement.^"
Distraction osteogenesis was used in combination with BMP-2 on the posterior

alveolar ridges of Macacafascicularis monkeys. One side of the mandibular served as a

base line without the use of BMP,and the other side was injected with a BMP cytokine

into the distracted area using a collagen carrier.^ After eight weeks the two sides were
compared and the side where BMP-2 had been used showed accelerated bone healing.
This study showed that the combination of distraction osteogenesis and BMP-2 produce

maximum bone enhancement of the distracted segments, which in this case produced an

increased height of the alveolar ridge without the use of bone grafting.'*
Two-month-old minipigs were used in another study to observe the rate of growth

of the cranium after a one-sided defect of the parietal bone (including the coronal suture)
was generated. One group was not treated, the second group had an autogenous iliac
bone graft, and the third group was repaired with rhBMP-7 collagen (500 mg/g) and
carboxymethylcellulose. After four months, the first group had major bony gaps
remaining, the second group had minor bony gaps remaining with significantly less bone
volume than the non-defect side, and the third group had bony continuity in all cases with
no significant differences in the treated vs. non-treated sides. Skull diameters increased

by 16.4%, and the physiological centrifugal cranial expansion remained undisturbed.^^
A research team in Australia set out to evaluate the role of BMP-2, BMP-4, and

TGF-beta superfamily related postreceptor signaling glycoproteins Smads 1-5 in
distraction osteogenesis. (Smads are the intracellular modulators for the extracellular

binding of TGF-beta superfamily molecules to the serine/ threonine kinase receptors.)
They used 12 sheep;6 had their mandibles distracted Imm/day, and 6 were distracted
4mm/day. Each group was distracted 24mm, and then allowed a five-week fixation
period. No significant difference between the two groups was noted. In fracture healing,

BMP-2 and BMP-4 have been localized in the cambial layer of the periosteum, where

healing occurs by intramembranous ossification. This study supports induction of BMP2 and BMP-4,their related smads 1-5, and intramembranous bone formation associated

with mechanical strain in distraction osteogenesis.

Maxillary bone deficiencies, such as cleft palate and underdeveloped maxilla that

require bone graft or regeneration after orthopedic or surgical expansion, pose a
significant biochemical burden. To accelerate bone formation in acutely distracted
palatal sutures, rat organ cultures were stimulated with Nell-1 or BMP-7 for 8 days in
vitro. Cowan et al. hypothesized that Nell-1 stimulation of the distracted palatal suture
would accelerate bone formation. Alcian blue staining was used for cartilage
localization. While both BMP-7 and Nell-1 produced significantly more bone and
cartilage, BMP-7 induced both chondrocyte proliferation and differentiation, while Nell-1

accelerated chondrocyte hypertrophy and endochondral bone formation. This suggests

distinctly different mechanisms that produce similar results.^
In a study by Chen® the expression of BMPs was monitored in 12 cats at 2,4,6, 8,
or 12 weeks. Cleft palate defects were distracted at a rate of 0.4mm 2/day. BMPs were
expressed as early as 2 weeks, with the most extensive expression in the 4-6 week range,

gradually tapering off in the 8-12 week range.® This study gives a good base line for
what occurs naturally with regards to BMP expression.

Another variable to consider is the age of the subject when using BMPs. While it
has been shown that 20 year-old monkeys (equivalent to the 80 year-old clinical patient)
can regenerate bone comparable to that of an 8 year old or middle aged monkey, it has

been reported in the literature by Fleet et al. in 1996 that animal aging decreased the
amount of rhBMP-2 induced bone in rats. It was postulated that this decreased induction
may be due to a decrease in the number of mesenchymal stem cells in older rats, or to a

change in the response of the target cells to BMP-2.^

A review of literature on BMPs revealed a number of interesting findings. For
example, mice deficient in BMP-2 have developmental abnormalities of the skull, hind-

limb, and kidney. A dose-dependent occurrence of cyst-like bone voids was also noted in
these animals. Other studies showed no relation between the concentration of BMP-2

and the amount of bone formed.'"^ The biomechanical performance of the defects that had
been treated with the lowest dose of rhBMP-2(150 mg)was superior to that of the
defects that had been treated with the higher doses, and this finding was attributed to the
lack of cyst-like voids in the lower dosed animals. This evidence suggests that the dose

of rhBMP-2 protein may have to be adjusted for different clinical applications.'"' In
another study'"*, the presence of voids in the fusion mass was noted in two cases in which
either an open-cell polylactic-acid polymer or a polylactic-polyglycolic acid carrier was
used. The authors concluded that further study should be conducted regarding the

influence of the protein dose and a specific carrier on the formation of these voids.
Although these preclinical studies have been promising, the relatively high doses of

rhBMP required to induce adequate bone formation suggests that large amounts of
recombinant protein may be required to produce a clinically important effect. The
carriers that have been tested most frequently are a collagen matrix, demineralized bone
matrix, and synthetic polymers. It is unclear whether these are the best vehicles for

presenting BMPs(or growth factors) to receptors or responding cells.

Lieberman goes

on to say that he believes that fibroblast growth factor is the most clinically promising

stimulator of bone repair (as opposed to BMP),saying that a dose response is not found
suggesting a threshold amount of rhFGF-2 will enhance bone-repair, but a higher dose

will not improve healing.''^ It is worth noting that BMP-2 and BMP-7 have received FDA
approval for human clinical uses and have entered the market on a global level.
In the process of healing a bone fracture a callus is formed. Distraction

osteogenesis takes advantage of the fiberous callus and stretches it about Imm/day to
gain length. The rate of bone callus formation with DO is said to be about twice that of

fracture gap healing.'® Without the use of BMP,it is standard practice to wait one
sometimes two weeks for the callus to form after an osteotomy is done.^ A study done in
Japan'® evaluated the callus formation in the femur of rabbits with distraction
osteogenesis. A significant increase in callus formation was found in the group where

BMP and a polymer-coated gelatin sponge (carrier) were used. These rabbits were
subjected to DO immediately after surgery, and still they exhibited good callus formation
2 weeks some in only one week after surgery. Afer six weeks, the formation of bone
cortex and marrow cavity was almost complete, where as in the other specimens where

no BMP was used only a good callus had formed and the cortex was thin. Torsional

strength tests confirmed the maturity of the bone where BMP was used.'® It has been
suggested that only 3-4 days are necessary for recovery of the periosteum and less than
one week for that of the intermedullary blood supply to take advantage of the higher rate
of BMP to accelerate callus formation.^' The concentration of rhBMP-2 with PGS has

been shown to be gradually reduced into half after 3-4 days, 10% after 10 days, and 0.5%

three weeks after osteotomy. Thus, rhBMP-2 with PGS exhibited sustained release for

up to three weeks.^"* Without any delivery system, rhBMP-2 injected locally remained in
place for about 7 days.'

Histologically, DO exhibits mainly intramembranous ossification, which occurs in

the central portion called the fiberous interzone/^'^^ By contrast, endochondral
ossification occurs at either end of the distraction site after the invasion of the vessels

from the intramedullary tissue. Yasui et al. found that intramembranous ossification

occurred mainly during DO, but endochondral ossification occurred only during the early
phase.

It was suggested that this may be due to the higher concentration of rhBMP-2

in the early phase.'

CHAPTER THREE

MATERIALS AND METHODS

Surgical procedures were carried out in a special room in an animal care facility at
Loma Linda University, staffed by a fulltime microsurgery technician, John Chrisler
who performed all surgical procedures on the rats. Micro CTs and the micro MRl were

performed by Dr. Andreas Obenuas and Anna Smith. The titanium cages were
constructed in two different labs; the non-expansion cage was made from titanium mesh

(Osteomed)that was welded to form custom cages by Dr. William Nordquist, DDS,and
the distraction cages were cast titanium wire cages that were engineered specifically to
attach to the distractor(KLS Martin) with screws(American Orthodontics). These cages

were designed by Andrew Christiansen and Nick Elannery at Medical Modeling.
Medtronic supplied and Jonathan Brunger prepared the concentration of rhBMP-2 prior
to each set of surgeries, histological slides were done by John Hough, while the TRAP

stain (Sigma) was prepared by Dr. Ken Wright. A list of supplies and instruments can
be found in Figure 1. Figure 2 shows a sterile set of instruments with two nonexpansion cages in sterile saline ready for surgery. Figure 3 shows the distraction cage
apparatus fully assembled.

12mm titanium distractor fabricated by KLS Martin
Two cage types:
1) Non-distraction cages fabricated by William Nordquist, DDS
24mm x 8mm x 6mm of titanium sodered mesh from OsteoMed

2) Custom designed to fit the distractors, cast titanium distraction cages each
10mm X 8mm x 6mm fabricated by Medical Modeling
Four screws or locking pins to attach the distractor to the two cages fabricated and customized by
American Orthodontics

ACS(Absorbable Collagen Sponge) One sponge for the non expansion cages, 1.5 sponges per
expansion cages from Medtronics
1.4mL of 0.3mg/mL rhBMP-2 per sponge from Medtronics
Rats white SD 290-415g
4-0 Vicryl P3 or Pe3 suture
4-0 Proline Ps3 suture
#15 Bard Parker blade
Scissors
Hemostats

Variety of forceps
Tuberculine syringes
25-27gage x lin needles
Triple antibiotic ointment
Opthalmic ointment

Figure 1 List of essential instruments for initial surgery.

Figure 2 Instruments and cages in sterile saline.

Figure 3 Distraction cage.

Rat Selection

Step 1

Rats were selected by size and sex in order to have a standardized group without
extremes. Male Sprague-Dawley rats weighing 290-415g grams were used in this study,
with the average weight being approximately 325g.

Implant cage preparation
Step 2

In this study, both the screws and the cages to be implanted in the rats were

custom made and needed some modifications prior to assembly. The threaded portion of
the 2mm diameter screw was ground flat on two sides. Then just below the screw head
the threads remaining were shaved down with a bur to make a square midsection I mm x
Imm for about I.5-2mm in length along the shaft. By leaving the end rectangular, the
screw acted like a locking pin. One quarter turn of the screw kept the arms of the

distractor snug against the drilled out slot in the cage that was just large enough for the
rectangular end of the screw to pass through. All the pieces were assembled prior to
sterilization of the parts as shown in Figure 4, to make sure no further modifications

needed to occur. The distractor attached to the cage was tested for its ability to expand.
This was because the cage would get hung up on the distractor at around 4mm of
distraction and no further expansion could occur. The necessary modifications were
made and the cage was sterilized along with the distractor, screws already assembled and
Howe pliers and screw driver to put it back together if it came apart post sterilization.

The non-expansion cage required no prep or assembly. Figure 5 shows the window
where the collagen with rhBMP-2 was placed into the cage.

Figure 4 Profile view of the distraction cage.

Figure 5 Non-expansion cage containing collagen.

RhBMP-2 Preparation
Step 3

Collagen and rhBMP-2 preparation was the most technique sensitive part of this
process. We followed the instructions given by Medtronic, Inc. when possible. For a
collagen sponge lin. x 2 in. x l/4in, we added 1.4ml of the BMP solution to the shiny
side of the sponge and allowed it to soak on a surface that does not absorb moisture (as
shown in Figure 6)for a minimum of 15 minutes and a maximum time of 120 minutes.

In order to place the BMP and collagen sponge into the cage without mutilating the
absorbable collagen sponge(ACS)it was necessary to cut the collagen sponge prior to
soaking it in BMP. The size was determined by cutting the collagen slightly larger than

the cage or cells in the distraction cage it needed to fill. After the collagen sponge was
soaked in the BMP solution it quickly became like wet tissue paper and fit easily into the
cell or cells it was cut to fit in (see Figure 5). The spaces inside the cages were filled
with the sponge, but the cages were not overpacked because overpacking caused the
BMP solution to be squeezed out.

The dimensions of the distraction cages were 8mm x 10mm x 6mm for each of
the two pieces for a totally assembled size of 8mm x 21mm x 6mm. The materials
required for a cage this size are 1 ACS (or 3 in x 1 in x l/4in of collagen sponge)and

2.0ml of 0.3mg/ml rhBMP-2. Only one ACS and 1.4cc of 0.3mg/ml rhBMP-2 was
required for the non-expansion cage.

Figure 6 Adding rh-BMP-2 to the ACS.

Rat anesthesia

Step 4

Rat anesthesia was done two ways. Phenobarbital was not used because of the

risks of overdose and the long recovery time. Once a technique for placement was

established, it became much more practical to use 5% Isoflurane initially, and when the
rat was asleep the Isoflurane was reduced to 2-2.5% depending on the tolerance of the
rat. The cone used for the delivery of the Isoflurane is shown covering the rat's face in

Figure 7. This way, the initial anesthesia was rapid, profound, and had a large margin of
safety with an almost immediate recovery. The only drawback was the increased blood

flow at the surgical site. Initially, Ketamine 80mg/ kg and Xylazine 6mg/ kg were given
IP as shown in Figure 8. A maintenance dose of 20mg or O.Icc of Ketamine was used if
the rat began to wake before the procedure was done or if the rat had built up a tolerance
from prior administration of these drugs from the prior surgery. Ophthalmic jelly was

placed on the rats eyes, particularly when using Ketamine because this drug dried out the
rat's eyes rapidly.
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Figure 7 Inhalation anesthesia

Figure 8 Anesthesia given IP

Surgery Preparation
Step 5
The site was shaved prior to the incision, and a hair removal cream was used for a
short time so the skin did not become too irritated. The site was sprayed or doused with

Betadine® solution. All instruments used were sterilized by autoclave, and a sterile field
was prepared to perform the surgery. We wrapped tape around the feet of the rat, and

tacked the tape to a surgical board away from the body of the rat as shown in Figure 9.
The cone used to deliver the 5% Isoflurane to the rat was adjusted and tacked down to
optimize anesthesia delivery to the rat.
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Figure 9 Rat prepared for surgery.

Figure 10 Coronal incision.

Cage Placement
Step 6

A coronal incision was made just behind the scapulae for the non-expansion cages
shown in Figure 10 and 11, while a lengthwise incision of about 3cm was made for the
expansion cages as shown in Figure 12. The incisions were made through both the thick
skin and the investing fascial layer giving access to the spinotrapezius muscle. The two

anterior corners of the cages were tacked with one nylon suture to each side of the

exposed muscle. A double layer closure was done to encapsulate the cage. The first
closure was the muscle's fascial layer under which the cage is implanted. The second
closure was the skin layer.

Figure 11 Mesh cage placement.

Figure 12 Distraction cage placed.

Around day 7 or 8 after implantation a seroma, like the one shown in Figure 13,
had formed around the implanted cages with the BMP-2 in all but one rat. If the seroma
appeared to cause discomfort, it was reduced by aspiration of the fluid surrounding the
cage. Between 5-7cc of fluid was aspirated in one group of(three) rats.

4
Figure 13 Seroma formation.

Figure 14 Hemostats attached to knob.

Distraction Osteogenisis
Step 7

By this time(specify time) a thick capsule formed around the implanted cage and

in all cases some serum was present within it. An incision was made the length of the
cage to access the tissue between the two cages. The tissue was then cut with a #15 Bard
Parker blade and the wound was closed. Twenty-four hours later, a small incision was
made just wide enough to access the knob of the distractor with a hemostat. The

hemostat locked on to the distractor knob is shown in Figure 14. Beginning on day 15
post-implantation, the distractor knob was turned 2 full turns clockwise once a day for 7
days to expand the cage 2/3 mm per day. Expansion was halted after 7 days(day 22 post
implantation) and held for one or two weeks.

Intravital Fluorescent Labeling
Step 8

Intravital fluorescent labeling by tetracycline was used as a bone marker to show
whether bone was still forming or mineralizing. Since the peak calcification is reported

to be approximately three weeks'® after implantation, a tetracycline marker was
administered at that time. If the bone was still mineralizing, the tetracycline would

incorporate into the forming bone matrix, thus causing the bone to fluoresce when viewed
under an ultraviolet light. This method was also useful in telling where the bone was
forming during the 3-4 days it took to clear the tetracycline after injection. We
administered 15-20mg/kg tetracycline in sterile water solution to a total volume of 3-4mL

intraperitonially (IP) at three weeks. In the next study group, oxytetracycline will be
administered I5-20mg/kg in 3-4ml of sterile water IP at five weeks to produce a
contrasting color of fluorescence and ascertain whether or not the bone is still
regenerating.

Micro-CT

Step 9

The CBCT images were taken anytime a change in calcification was expected. An
initial CBCT was done on all seven rats to show initial bone density. Change in density
was observed in one week intervals after the three weeks it took to grow bone. Since
there is possible damage caused to bone formation with every CBCT taken, no more
than three CBCTs were taken per rat, and done at least one week apart. By taking serial
CBCTs, relative density can be assessed with out surgical intervention. We obtained
CBCT data within 24 hours after placement, at(post-expansion) three weeks, and at four
weeks after implantation.

Micro-CT Equipment

All exposures were performed using a micro X-ray computer tomography

(micro-CT) unit(MicroCAT II®, ImTek Inc., Knoxville, TN)with an 80 kVp X-ray
source and a reconstruction volume resolution as low as 15 microns(ImTek,Inc.

specifications). The scanner is a "step and shoot" type system, which rotates a low-

power X-ray source and an X-ray detector array about the specimen. Data acquisition is

controlled by the MicroCAT II® software, which operates on a Windows XP® work
station. X-ray data sets are stored on the system computer hard drive and reconstructed
simultaneously with the acquisition of the scan.

Micro-CT Data Acquisition

Each animal was scanned, while anesthetized with 2.5% Isoflurane, using 75
kVp at 1000 pA with 360 projections per scan. The CCD camera exposure time for each
projection was 200 msec. The source to center distance was 386.14 mm and the source
to detector distance was 511.14 mm. One positioning radiograph and 25 light: 25 dark
calibration measurements preceded each scan.

Micro-CT Image Reconstruction

All micro-CT images were acquired using a CCD field width of 2048 pixels and
length of 2048 pixels with 4x4 data binning. The images were reconstructed using a
Shepp-Logan filter and real-time reconstruction. Reconstructed volumes were 512 x 512
X 512 voxels with 0.126 mm voxel dimensions. All reconstructed images were

visualized using Amira® software(TGS,Inc.)

Specimen Retrieval and Processing
Step 10

Surgical cage removal for both cage types was done with a straight incision
slightly longer than the cage as shown in Figure 15. The capsule had become thick and

tough to cut through at this point. The cage was dissected from the surrounding soft
tissue and removed as shown in Figure 16. After checking for bone with a needle tip the
cage was immediately placed in 10% neutral buffered formalin fixative solution for a
minimum of 24 hrs. The cage was then cut in half with an Exakt diamond band saw to
allow the formalin to fully perfuse the tissue.
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Figure 15 Mesh cage removal.

m

Figure 16 Distraction cage removed.

Analysis of Specimens
Step 11

Analysis of the specimens was done with CT three dimensional reconstruction,

and gross visualization. Histological analysis was done on only half of each specimen.
The other half was preserved for gross observation and preservation of the tetracycline
induced fluorescence.

Histological analysis
Step 12

Decalcification was done with 15% neutral buffered EDTA for histologic
analysis. It was necessary to decalcify the bone to be able to peel it out of the titanium

cage and cut it 5 microns thick without fraying the tissue. The bone was submerged in

3L of 15% neutral buffered EDTA for two weeks(one week was not long enough), then
processed for paraffin embedding. The stains used were the standard H & E(Hemotoxin

and Eosin) and a TRAP(Tartrate Resistant Acid Phosphatase)(Sigma) histochemical
method to stain osteoclasts.

CHAPTER FOUR
RESULTS

Marked bone formation occurred in all 6 rats. A concentration of 0.3mg/ml
rhBMP-2 formed considerably more bone than did a concentration of O.lmg/ml. The
concentration of rhBMP-2 affected the tissue type formed. In the cage with the
O.lmg/ml concentration multiple tissue types were formed; some bone, some tendon-like

tissue, some dense irregular connective tissue, some areas were highly cellular, and some
areas of bony matrix were devoid of a single cell. In one area, the (presumed) bone
appeared in thin spicules, forming a reticular pattern that is unlike any tissue recognized
in the human body. The samples were all highly vascular. Bone formed continuously
across the 4 mm expanded portion. Viewing it grossly, bone appeared only along the
base of the cage when observed 7 days post expansion (or a total of 28 days post
implantation). A dense connective tissue capsule formed around the implanted
expansion cage. There was evidence of hyaline cartilage formation within the muscle's
fascial layer that encapsulated the cages. Surrounding the hyaline cartilage were cells
with the same orientation as one would expect to see in tendon or ligament(or a thick
periosteum). On the outer edge of the cartilage were small areas that appeared to be
transforming into bone. A tissue sample of the capsule was taken at the time of cage
removal at 28 days post implantation. It was harvested near the site that was re-opened

once a day for 7 days to turn the distraction knob. Within this capsule was some
cartilage adjacent to some bone with a (presumed) periostium/perichondrium

surrounding it. On the same slide was found another (presumed) periostium capsule
filled with fat cells.

The optimal concentration of the rhBMP-2 in solution for a rat of this size was

found to be 0.3mg/ml. When we tried to conserve BMP by soaking another sponge in
the liquid remaining from the 1.4cc added to the first sponge, significantly less bone
formed. The liquid that was left over likely had a lower concentration of BMP than the
initial solution because much of the BMP had bound to the collagen sponge leaving
behind the neutral buffer solution

Figure 17 Bone formed with O.lmg/ml concentration rhBMP-2 with cyst-like voids
harvested at 3 weeks.

Figure 18 Bone formed with 0.3mg/ml concentration rhBMP-2 harvested at 3 weeks.

Figure 17 shows unfixed sections of the specimens from the pilot study were
O.lgm/ml rhBMP-2 was used. Note the fluid filled vacuole (or void) in the center of the

cage. A cage from an animal using 0.3mg/ml rhBMP-2 is shown in Figure 18. Note the
dense bone formation along the whole inner border of the cage. Both were removed on
day 22 postimplantation.
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Figure 19 Bone formed with 0.3mg/ml rhBMP-2 harvested 24 hrs prior to this photo on
day 25 after implantation.

Figure 20 Intravital fluorescent labeling shown under a UV light. The yellow/green
area is the bone that formed after three weeks in a distraction specimen cut in half.

Figure 19 is a raw cut of the bone formed with 0.3mg/mL rhBMP-2, removed at
25 days post-implantation. Notice the cortical bone forming outside the cage and a
marrow cavity in the center. Figure 20 is a distraction cage cut in half under a UV light
to expose the bone that took up the tetracycline marker given at 3 weeks. The

yellow/green area is bone that mineralized after 3 weeks. The blue is the UV light
reflecting off of bone formed prior to 3 weeks. In the center is the immature distracted

bone or callus not yet fully mineralized. This cage was removed at 4 weeks post
implantation. Note the difference between the composition of the centers of the two
cages. There is a marrow cavity in the non-expansion cage, and dense bone in the center
of the two halves of the distraction cages.

Figure 21 TRAP stain (red cells) in a 0.3mg/ml rhBMP-2 specimen showing osteoclasts
between periosteum and intramembranous bone.
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Figure 22 TRAP stain in a O.lmg/ml rhBMP-2 specimen showing osteoclasts (dark red
cells) along endochondral bone.

Above are sections stained for TRAP to show osteoclast activity (osteoclasts are

red). Figure 21 is a 0.3mg/mL rhBMP-2 specimen at 20x showing osteoclast activity
between the cortical bone and an apparent periosteal layer. Figure 22 is a O.lmg/mL

rhBMP-2 specimen at 40x showing osteoclast activity on a small spicule of bone in the
center of the cage. Stages of both intramembranous and endochondral bone formation
could be observed histologically. Osteoblasts can be observed along the borders of the
bone.

V!

r

.

V'

\

Figure 23 The bottom of a 0.3mg/ml rhBMP-2 distraction specimen harvested 28 days

post implantation. Note dense bone formation continuously between the two cages just
one week post expansion.

Figure 23 is the distraction cage right after removal at 28 days with the 0.3mg/mL
concentration rhBMP-2. The soft tissue was scraped away with a 15 blade to show the
continuous bone formation along the base between the two cages.

Figure 24 Endochondral bone formation in the muscle fascia! layer.

Figure 25 Magnification of 40x showing endochondral bone formation. Note the
chondrocytes in the center and bone forming on the periphery.

Above is a sample taken from the capsule which formed around the implanted
cage. Figure 24 is shown at lOx, and figure 25 at 40x to show the chondrocytes in the
center and the oseocytes at the bony periphery. This dense irregular connective tissue
fascia now contains a uniform orientation of cells surrounding the islands of cartilage and

bone. This layer will likely become the periosteum surrounding the forming bone, which
is going through a cartilage phase.

Figure 26 Tissue not found in the human body. This section was taken from the
0.Img/ml rhBMP-2 specimen. It is possible it could be the collagen matrix and red
blood cells
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Figure 27 This tendon-like tissue was found adjacent to the cyst-like void in the
O.lmg/ml rhBMP-2 specimen.

Figure 26 and 27 are both sections taken from the specimens formed with

O.lmg/mL rhBMP-2 to show the variety of tissue types formed. Figure 26 shown at lOx
is unrecognizable tissue with very thin, reticular matrix devoid of cells. It is surrounded

by red blood cells. It is likely that this is the collagen sponge. Figure 27 is what appears
to be tendon at 40x. The cells are all oriented in the same direction, and there is no bone

in this area of the slide. This tissue is near the fluid fdled void seen in Figure 17 with
many red blood cells adjacent to it.
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Figure 28 Three-D reconstruction of the CBCT image taken of the non-expansion
specimen on day 21 post implantation. Bone of the spine and scapula are included for
relative density reference.

y

Figure 29 Same as Fig.28 only cut in the center to view inside the cage. Both scapula are
shown for relative bone density reference.

Above are 3-D reconstructions using CT images taken on a 0.3mg/mL rhBMP-2
animal with a non-expansion cage just prior to removal at 25 days. In Figure 28 the cage
has been made somewhat transparent in order to visualize the bone and some cartilage
formation. Note a section of the rat's spine and scapula for comparison. Figure 29 is to
differentiate the bone densities formed in and around the cage. Note the bone that is the
densest formed adjacent to the titanium mesh as seen by the transparent orange color.
The image was set to show a minimum density equivalent to that of the rats own
skeleton. The large sections of floating bone are the scapula of the rat.

Figure 30 Bone formed in distraction specimen 7 days post expansion. CBCT was
taken 28 days post implantation. Relative densities are color coded. The tan color is the

normal bone density, the red color is very dense bone that likely overlaps with the
titanium cage, and the blue is strictly the titanium.
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Figure 31 Same specimen as in Figure 30, only cut through the center and rotated to

view about 20 degrees above the horizon. The rat's spine is shown on the bottom and its

scapula is shown on the left for density references.

Figure 30 is a 3-D reconstruction of the distraction cage as viewed from the side,

while Figure 31 shows the same cage cut in half viewed about 20 degrees above the

horizon. The relative densities are 1600-2999 for the bone, 3000-3999 for the very dense
bone in red, and 4000 and above for the titanium cage in blue. These parameters were set
visually relative to the spine of the rat shown below the cages.

Figure 32 Same as Figure 30 and 31 viewed from above the head of the rat towards the

tail to get an idea of the general pattern of bone formation.
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Figure 33 Coronal cut through the first titanium cage.
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Figure 34 Coronal cut just behind the first cage to show all the bone formed between the
two cages being distracted. Note the titanium distractor on the top and the rat's spine
and rib cage shown below.
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Figure 35 Coronal cut through the second cage at the level of the locking pin to show
dense bone formation surrounding the titanium screw.

Figure 32 to Figure 35 are cuts through the same distraction specimen as in Figure
30 and 31 except they are viewed longitudinally. The front of the cage as well as the
distractor are covered with a thin layer of bone as seen in Figure 32. The titanium grid of
the first half of the distraction cage can be seen in Figure 33. The central part between
the two cages where distraction osteogenesis occurred is shown in Figure 34. In the
second half of the cage there is a lot of dense bone. The bone surrounding one of the
titanium screws can be viewed in Figure 35.

CHAPTER FIVE
DISCUSSION

Perhaps the most clinically significant finding from this study is that it
demonstrates the possibility that patients can be their own autogenous bone bank.
Furthermore, this study also shows the feasibility of enhancing ectopic bone formation
with distraction osteogenesis. This is significant in that a maximum amount of bone can
be placed in a given area that the soft tissue can accommodate. The bone can then be

expanded through distraction osteogenesis at a rate at which the connective tissue and

fascia can regenerate without dehiscence. These findings have many possibilities for
use in surgery such as cleft palate repair, in repairing sites of bone loss caused by
infection, cancer, and trauma, reconstructive and plastic surgery, orthopedic surgery in
general, or simply to enhance cortical bone adjacent to temporary orthodontic anchorage
devices. It would be interesting to see if by using rhBMP-2 we could solve the
complications caused by chronic use of bisphosphonates. Since it is a problem of signal
differentiation between osteoclasts and osteoblasts, maybe by adding rhBMP-2 it will
help regain its ability to "differentiate" in intercellular communication. (A possible
application in veterinary medicine may be in the treatment and prevention of laminitis in
cows and horses.)

The dose concentration of 0.3mg/ml is considered a "mega level" dose for this

size of an animal. However, due to the rapid metabolic rate in the rat, it was necessary to
use this dose to gain results. The amount of collagen and rhBMP-2 implanted compared
to the rats' body mass would also be considered a mega dose. However, the rats were

able to fill this relatively large cage with bone. All rats survived these procedures,
except for one (due to a tetracycline overdose caused by a non-calibrated scale).

One interesting observation was an apparent dose-related variation in tissue types.
It is well documented that BMP-2 is indicated in the formation of tendon, ligament,

bone, and cartilage.'"^ We have observed through histology the presence of all of these
tissue types in every sample at every observed time.
The fact that the bone formed first, and possibly, only along the base of the
distracted cages would not surprise those who have studied contour formation of bone, or
those describing the piezoelectric effect of matrix surfaces. According to one study done
in vivo, the changes in electrical fields at the bone surface are predominantly those

originating in the muscle, indicating that the local electrical phenomena generated by
bone strain cannot be the only factors initiating the cellular response that is responsible
for bone remodeling. In fact, the local factors generated by bone strain appear to be over

ridden by the electrical fields generated by the muscle.'^ This may be a factor when
considering the fact that the most bone was formed and regenerated by distraction
osteogenesis along the surface that was in contact with a major muscle group. An
interesting test would be to flip the cage on its back to see if the bone would still form
along the base when the distractor is between it and the muscle. Would the bone form

and remodel significantly differently?

A possible explanation for the dense cortical bone formation adjacent to the
titanium cage could be the influence of geometry on the control of cell growth. Studies
have shown that the major difference between inhibited cells and their proliferating
counterparts is their shape. Cells in suspension are rounded, whereas cells attached to

plastic (or glass, or steel, and possibly titanium) are flat and spread out. Inhibition of
growth in the spheroidal state is characteristic of the majority of normal (untransformed)

fibroblasts and epithelial cells. Cells of hematopoietic origin are exceptions and can
proliferate while spheroidal and in suspension culture. The "flat" configuration is the
signal that gives "permission to proliferate". Isolated fibroblasts in agar, if they are
allowed to stretch in one dimension, will grow on glass fibers as thin as 0.05 um. This

approaches the dimensions of collagen fibrils."
There were many variables in this study, such as the affect of growing bone in a
titanium cage and how that affects the longevity of the bone that is formed, the effect of

taking multiple CTs of this forming bone, the rate at which the distraction cage should be
expanded, the optimal concentration of rhBMP-2, and the cage design itself. In this
study, only the concentration of rhBMP-2 was altered.

Other studies that may follow this one could investigate under what doses and
under what circumstances these various tissue types form. More questions arise than are

answered by this type of research; for example, is it possible to create a titanium cage that
will allow distraction osteogenesis of the spine for crushed vertebrae, spinal infections, or
oncologic surgical defects? Is there a localized method to reverse osteoporosis? Could
collagen strips laden with rhBMP-2 be used for cosmetic maxillofacial surgery and
plastic surgery,(e.g. the bridge of the nose)?

Further studies should be conducted to test the length of time that the ectopic bone
remains without resorption. Further quantitative analysis should also be performed on
these studies. More samples of the capsule should be taken from various locations to

check for consistency of the change in tissue type, specifically cartilage development.

Still other studies should be done to test if the ectopically formed bone can be
transplanted to critical areas for repair and survive. Some of these questions will be
described in Part II of this study.

CHAPTER SIX

CONCLUSIONS

A concentration of 0.3mg/ml rhBMP-2 formed optimal bone in the described rat

model at a dose of I.4cc-2.Iml. A concentration of O.lmg/ml rhBMP-2 formed multiple
tissue types with some, but very little bone at a dose of I.4ml in a rat model.

In this study, bone continued to form between 21 and 28 days in both the
distraction osteogenesis and the non-expansion cages. Therefore, it is believed that the

cages should be left in the rats for a longer time (4-5 weeks)to observe any difference
between non-expansion and expansion models regarding sustained bone formation.
The densest bone was observed adjacent to the titanium surface of the cage,
screws, and distractor.

In the distraction model, bone formed primarily along the base of the cage in the
distracted portion.

Dense bone formed around the titanium screws by day 28 without any significant
forces placed on them.
More bone formed outside the titanium cage on the anterior end than the posterior
end of the cage in all specimens.
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